TY - JOUR T1 - Twelve item multiple sclerosis walking scale: analysis through nursing diagnoses JO - Revista Científica de la Sociedad Española de Enfermería Neurológica (English ed.) T2 - AU - del Rio,Marina González AU - Merchan Ruiz,Miguel SN - 2530299X M3 - 10.1016/j.sedeng.2019.05.001 DO - 10.1016/j.sedeng.2019.05.001 UR - https://www.elsevier.es/en-revista-revista-cientifica-sociedad-espanola-enfermeria-447-articulo-twelve-item-multiple-sclerosis-walking-S2530299X19300172 AB - IntroductionAltered gait is one of the most common symptoms of multiple sclerosis. Fampridine is recommended to control this symptom. Its clinical benefits are assessed by timed and subjective tests, such as the 12-item MS walking scale (MSWS-12). Determining patients’ responses using the MSWS-12 enables nurses to identify, evaluate and monitor NANDA diagnoses relating to mobility. AimTo analyse the effectiveness of the MSWS-12 in relation to NANDA diagnoses in monitoring subjects with MS who are responders to fampridine. MethodsObservational, descriptive and retrospective study from October 2017 to September 2018 In Girona’s Unitat de Neuroimmunologia i Esclerosi Múltiple Territorial. A total of 17 fampridine responders were included in the study. Variables: age, sex, EDSS and baseline MSWS-12 scores, at 15 days, and at 6 months. ResultsAn increased total MSWS-12 score was observed between 15 days and 6 months of: impaired walking x̄=1.9 (p=.076); impaired standing x̄=.2 (p=.637); fatigue x̄=.9 (p=.209); risk of falling x̄=.6 (p=.270). ConclusionImpaired walking and fatigue had a greater tendency to worsen over time. Risk of falling and impaired standing had a more stable score. The MSWS-12 in relation to NANDA diagnoses is a useful tool for nurses to monitor people with MS and altered gait. ER -